Your browser doesn't support javascript.
loading
Editorial: Community series in novel insights into immunotherapy targeting tumor microenvironment in ovarian cancer: volume I.
Di, Xiang-Jie; Zhao, Qi; Wang, Hai-Tao; Wei, Xia-Wei; Liang, Xiao.
Afiliação
  • Di XJ; Key Laboratory of Obstetrics & Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Zhao Q; Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, Clinical Trial Center/NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, West China Hospital, Sichuan University, Che
  • Wang HT; Ministry of Education (MoE) Frontiers Science Center for Precision Oncology, Cancer Center, Faculty of Health Sciences, University of Macau, Macau, Macau SAR, China.
  • Wei XW; Thoracic Surgery Branch, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, United States.
  • Liang X; Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, Clinical Trial Center/NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, West China Hospital, Sichuan University, Che
Front Immunol ; 14: 1192190, 2023.
Article em En | MEDLINE | ID: mdl-37114065
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Microambiente Tumoral Limite: Female / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Microambiente Tumoral Limite: Female / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China